protein degraders

Showing 1 posts of 1 posts found.


Astellas and Cullgen enter into $1.9bn strategic collaboration to progress protein degraders

June 15, 2023
Research and Development Astellas, Cullgen, Oncology, protein degraders

Japanese pharmaceutical company Astellas and US-based clinical-stage biopharmaceutical company Cullgen have announced that they have entered into a strategic research …

Latest content